Clinical Trial Update: PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia [Phase 4]

View source ↗

Summary

This update notes the completion of the PRIOR Phase 4 study evaluating ibandronate (Boniva) in postmenopausal women with osteoporosis or osteopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Postmenopausal Osteoporosis

Drugs mentioned

• Boniva (ibandronate)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Postmenopausal Osteoporosis | Phase 4 | Status: COMPLETED